MarketBeat target leaves Neogen stock 8.01 percent below USD 12.67 target

Published on 10/20/2026 at 19:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Neogen raised fiscal 2027 revenue guidance to USD 885.00-890.00 million. Neogen stock costs EUR 10.45 on October 20, 2026 at 7:53 p.m. CEST.

Analyst target and guidance

MarketBeat lists a USD 12.67 consensus target based on 5 analysts.
Neogen raised fiscal 2027 revenue guidance to USD 885.00-890.00 million on October 6, 2026.
Neogen stock costs EUR 10.45 at Lang & Schwarz on October 20, 2026 at 7:53 p.m. CEST.

NEOG, US6404911066, Illustration mit AI erstellt.

Neogen Corporation (ISIN US6404911066) is paired with a USD 12.67 consensus price target based on 5 analysts, while its euro quotation stood at EUR 10.45 at Lang & Schwarz on October 20, 2026 at 7:53 p.m. CEST. MarketBeat lists the target and a Hold consensus.

Guidance moved higher

Neogen raised fiscal 2027 revenue guidance to USD 885.00-890.00 million from USD 880.00-885.00 million on October 6, 2026. Adjusted EBITDA guidance also rose to USD 181.00-183.00 million from USD 180.00-182.00 million, according to Neogen.

The change followed first-quarter fiscal 2027 revenue of USD 222.80 million for the three months ended August 31, 2026, up 6.50 percent from USD 209.20 million a year earlier. Adjusted EBITDA reached USD 41.60 million, with an adjusted margin of 18.70 percent versus 17.00 percent in the prior-year quarter, the company reported.

Price position stays measurable

Neogen's primary listing is on Nasdaq, where the stock was at USD 11.73 on October 20, 2026 at 1:57 p.m. ET. The 52-week range was USD 5.37 to USD 14.26, placing the quote 17.72 percent below the high and 118.44 percent above the low. Market capitalization was USD 2.56 billion and volume was 681,519 shares at that timestamp.

What does the target imply?

The USD 12.67 consensus target stands 8.01 percent above the USD 11.73 Nasdaq quote. The valuation picture is restrained by negative trailing earnings, with the primary quote carrying a P/E of minus 46.39 and no dividend yield.

Comparison with peers

Neogen: 0.86 percent higher on Nasdaq, P/E minus 46.39, market capitalization USD 2.56 billion.

Mercury Systems: 1.14 percent lower on Nasdaq, P/E minus 149.02, market capitalization USD 4.57 billion.

Henry Schein: 0.60 percent higher on Nasdaq, P/E 24.62, market capitalization USD 9.41 billion.

Upcoming operating milestones

Neogen plans to begin a multi-quarter Petrifilm manufacturing transition in November 2026. The company also expects regulatory reviews for the planned Genomics divestiture to conclude by the end of December 2026, according to the October 6 release.

Stock quotation in Germany

Neogen was trading at EUR 10.45 at Lang & Schwarz on October 20, 2026 at 7:53 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Neogen stock.